RAD51-IN-5

• UNSPSC Description:

  RAD51-IN-5 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-5 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2021164746A1, compound 3)[1].

• Target Antigen:

  RAD51

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/rad51-in-5.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  CC(C)S(=N)(C1=C(C2=CN=C([C@@]3([H])CC[C@@H](CC3)NC(OC(C)C)=O)S2)C=CC(NC(OC(C)C)=O)=C1)=O

• Molecular Weight:

  550.73

• References & Citations:

  [1]Peng Gu, et al. Substituted aryl compound. Patent WO2021164746A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2690367-19-0